Call to Action: Standardizing Follow-Up Care for Infants Prenatally Exposed to Opioids

Sara L Mills-Huffnagle1, Rhea E Sullivan1, Tammy E Corr1,2

  • 1Department of Neural and Behavioral Sciences, Penn State College of Medicine, Hershey, Pennsylvania.

Hospital Pediatrics
|February 6, 2025
PubMed

Insights

Neonatal opioid withdrawal syndrome (NOWS) is increasing. A standardized follow-up care protocol is needed for infants with prenatal opioid exposure to support families and providers, improving outcomes and reducing readmissions.

Area of Science:

  • Neonatal care
  • Pediatric medicine
  • Public health

Background:

  • Neonatal opioid withdrawal syndrome (NOWS) rates have significantly increased between 2007 and 2017.
  • Prenatal opioid exposure is linked to adverse neurodevelopmental outcomes in infants.
  • Current follow-up care for affected infants lacks standardization.

Purpose of the Study:

  • To advocate for the development of a standardized follow-up care protocol for infants with prenatal opioid exposure.
  • To emphasize the need for support systems for families and healthcare providers involved in NOWS care.
  • To address and overcome barriers to care for these vulnerable populations.

Main Methods:

  • This study is a call to action based on existing evidence and clinical observations.
  • It highlights the necessity for a protocol addressing family and provider challenges.
  • It suggests educational initiatives for families and providers regarding NOWS follow-up.

Main Results:

  • A standardized protocol can improve clinical practice and patient care.
  • Addressing barriers to care can enhance treatment adherence and effectiveness.
  • Improved follow-up may lead to a reduction in hospital readmission rates for NOWS.

Conclusions:

  • A standardized protocol for NOWS follow-up care is crucial.
  • Support for families and providers is essential for effective management.
  • Implementing this protocol can lead to better long-term outcomes for affected infants.